Artemotil or beta-arteether
- Level
- Commodity
- Parent
- 51101900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101918This classification denotes an antimalarial agent with the molecular formula C17H28O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XGL7GFB9YI, chemically known as 3,12-epoxy-12h-pyrano(4,3-j)-1,2-benzodioxepin, decahydro-10-ethoxy-3,6,9-trimethyl-, (3r-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12ar*))- but generally known as arteether, which bears US NIH Compound Identifier 72416. European Medicines Agency schedules Artemotil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00596MIG. The term ARTEMOTIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). World Health Organization schedules arteether in its Anatomical Therapeutic Chemical (ATC) Classification. Artemotil or beta-arteether bears US NLM identifiers UMLS ID C0052427 and NCI Concept Code C73002. SMILES: CCOC1C(C2CCC(C3C24C(O1)OC(CC3)(OO4)C)C)C.
Same parent
Under 51101900 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.